Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC

Specialties >>

AML
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
CLL
Colorectal Cancer
DLBCL
EGFR+ Lung Cancer
Follicular Lymphoma
Gastric Cancer
Genitourinary Cancers
GI Cancers
Gynecologic Cancers
HCC
Head & Neck Cancers
Hematology
HER2-Negative Breast Cancer
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
MPNs
Multiple Myeloma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Sarcoma
Skin Cancers
Thyroid Cancers

Partners >>

Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up

Targeted Therapies in Oncology
May 2013

Clinical Articles

A Guide to ASCO 2013: Key Targeted Trials
Numerous Drug Classes Studied for Use in Follicular and Other Lymphomas
Researchers Identify How Nongenetic Mechanisms of Cancer Cell Diversity Can Affect Treatment Response
New Developments in Oral Targeted Agents for Advanced Colorectal Cancer
Full Version of the May 2013 Issue
Biomarkers Still Needed in Prostate Cancer
Treating Elderly Patients With CLL
Spotlight on Novel Agents in Early Development
Trials Examine Use of T-DM1 as Combination Therapy for HER2 Breast Cancer
Notch Holds Promise, but Presents Obstacles as Cancer Target
Case-Based Discussion: Integrating Novel Agents Into the Treatment of Prostate Cancer
Bundled Payment: Practice Savior or Killer?
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.